Peptides in Argentina: Own Use or Resale

Importing a research peptide for your own laboratory and importing the same product with the intention of reselling it are two different operations under Argentine customs and under the law — not two volumes of the same operation. The difference is not the number of vials. It is the declared use, and what that declaration allows afterward: a researcher bringing material into their own programme does so under a research destination, while someone planning to resell is, in practice, trying to place a product on the market for which no health registration exists in Argentina — and that reclassifies the operation entirely.

What does "own use" mean for a research peptide import?

Own use means the material enters to be used inside the facilities of the person who imported it — a laboratory, a university, a research centre — and does not leave that circuit again. The invoice and the supplier's documentation describe the product for what it is: reference material for in vitro research, not a medicine and not a supplement. That framing is what applies to the peptides quoted in the PeptoClinic catalog: each one is supplied strictly for laboratory research use (Research Use Only, RUO), never for human or veterinary consumption.

What changes when the intention is resale?

Resale means the importer is not the end user. They buy a lot, split it or redistribute it, and hand it to third parties. That movement takes the product out of the frame of "reference material for one's own assay" and places it in a commercial distribution chain — the same chain that ANMAT regulates in Argentina for any product intended for use in people. A research peptide does not carry that registration, because nobody submitted it, evaluated it, or approved it as a medicine or a supplement before any national authority. Reselling it under that expectation — even if the label says "for research" — puts into circulation a product that has no authorization for the use the final buyer will likely give it. That is the real distance between the two operations: it is not a longer form to fill out, it is an activity the Argentine health framework does not contemplate as lawful.

Why does resale run into the lack of a health registration?

Because the Argentine system has no intermediate category between "laboratory material" and "product for human consumption." A compound is registered as a medicine, registered as a dietary supplement, or not registered at all — and research peptides fall into neither of the first two categories, because nobody submitted them for that. As long as the declared destination is laboratory research, that absence of registration is coherent with the use: nobody is going to consume it. The moment the destination shifts to resale, to people who are going to use it on themselves, the absence of registration stops being an administrative detail and becomes the central problem of the operation.

How does a research peptide enter Argentina?

The shipment arrives as what it is: a sealed vial of lyophilized powder, with the supplier's documentation stating a research destination. It does not travel in a cold chain — lyophilized powder is stable at room temperature for weeks, so the box carries no coolant and no dry ice, just the vial protected from light with its desiccant. That holds equally for someone importing a single lot for their own assay and for any other recipient: the shipping method does not change with volume. What changes is the declared use and what the importer does with the product afterward. This site explains the dispatch process into the country on the shipping to Argentina page, and the retatrutide country page covers what that looks like for one specific compound.

What documentation has to travel with the shipment?

At minimum, a commercial invoice describing the product as research material, and the lot's laboratory report — the certificate of analysis (COA) showing what an independent third party found when they tested it. PeptoClinic publishes reports from Janoshik Analytical: the one for retatrutide, for example, found a purity of 99.893% on the lot analysed, and the one for MOTS-c, 99.669%. That second figure is the lowest of the four published reports, and it's the one worth looking at before assuming every lot performs like the best one. The quality page explains how to read a certificate like this line by line, and what to ask a supplier who doesn't provide one.

Someone importing for their own programme needs that document to justify the nature of the material to customs and to their own institution. Someone planning to resell does not solve the underlying problem with a COA: the certificate says what is in the vial, it does not authorize distributing it for a use the health framework doesn't cover.

Is there a volume difference between the two operations?

Volume is not the variable that defines the legal category, although in practice a large lot with no declared research destination tends to be the signal that triggers stricter scrutiny. A researcher can import several vials of the same compound to replicate an assay, and that stays own use if the final destination is their own laboratory. Resale, by contrast, is defined by destination — the product going out to third parties — not by quantity.

Does PeptoClinic sell for resale?

PeptoClinic is a technical supply consultancy: every shipment is quoted after a technical consultation about the compound, the purity specification, the quantity, and the lot documentation needed for dispatch. The material is supplied for laboratory research, not as merchandise for commercial redistribution. A researcher who needs, say, BPC-157 for their own assay can inquire directly about the compound and receive the corresponding lot documentation.

The material is for laboratory research, not for use in people

Everything supplied under this catalog is classified strictly as Research Use Only (RUO): material for in vitro and laboratory research. No product is approved or intended for human or veterinary consumption, for diagnosis, or for treatment, and no claims about these compounds have been evaluated by ANMAT, the FDA, or any equivalent authority. Anyone looking for a guide to using these compounds in people won't find one here, because that is neither the purpose of the product nor the role of this consultancy.